Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
Molecular Vision
|
December 13, 2012
RB116: an RB1+ retinoblastoma cell line expressing primitive markers
Anthony Bejjani, Mee Rim Choi, Linda Cassidy, et al.
Scientific Reports
|
February 24, 2025
Caveolin 1 and 2 enhance the proliferative capacity of BCAM-positive corneal progenitors
Yuzuru Sasamoto, Shoko Kiritoshi, Catherine A A Lee, et al.
Investigative Ophthalmology & Visual Science
|
February 28, 2015
A Murine Model for Metastatic Conjunctival Melanoma
Nadine E de Waard, Jinfeng Cao, Sean P McGuire, et al.
Cancer Immunology, Immunotherapy : CII
|
June 27, 2009
Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells
Jacobus J Bosch, Uzoma K Iheagwara, Sarah Reid, et al.
Cancer Research
|
March 5, 2004
Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy
Samudra K Dissanayake, James A Thompson, Jacobus J Bosch, et al.
Investigative Ophthalmology & Visual Science
|
March 12, 2026
Essential Role of CD63 in Maintaining Corneal Epithelial Identity in the Human Limbus
Yuzuru Sasamoto, Kosei Suzuki, Shinri Sato, et al.
Iscience
|
July 1, 2021
Human iPS cells engender corneal epithelial stem cells with holoclone-forming capabilities
Shinya Watanabe, Ryuhei Hayashi, Yuzuru Sasamoto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 8, 2010
Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase
Sofia Theodoropoulou, Paraskevi E Kolovou, Yuki Morizane, et al.
Cancer Research
|
May 8, 2007
MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells
Jacobus J Bosch, James A Thompson, Minu K Srivastava, et al.
Investigative Ophthalmology & Visual Science
|
May 1, 2014
Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase
Ahmad Al-Moujahed, Fotini Nicolaou, Katarzyna Brodowska, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
Molecular Vision
|
December 13, 2012
RB116: an RB1+ retinoblastoma cell line expressing primitive markers
Anthony Bejjani, Mee Rim Choi, Linda Cassidy, et al.
Scientific Reports
|
February 24, 2025
Caveolin 1 and 2 enhance the proliferative capacity of BCAM-positive corneal progenitors
Yuzuru Sasamoto, Shoko Kiritoshi, Catherine A A Lee, et al.
Investigative Ophthalmology & Visual Science
|
February 28, 2015
A Murine Model for Metastatic Conjunctival Melanoma
Nadine E de Waard, Jinfeng Cao, Sean P McGuire, et al.
Cancer Immunology, Immunotherapy : CII
|
June 27, 2009
Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells
Jacobus J Bosch, Uzoma K Iheagwara, Sarah Reid, et al.
Cancer Research
|
March 5, 2004
Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy
Samudra K Dissanayake, James A Thompson, Jacobus J Bosch, et al.
Investigative Ophthalmology & Visual Science
|
March 12, 2026
Essential Role of CD63 in Maintaining Corneal Epithelial Identity in the Human Limbus
Yuzuru Sasamoto, Kosei Suzuki, Shinri Sato, et al.
Iscience
|
July 1, 2021
Human iPS cells engender corneal epithelial stem cells with holoclone-forming capabilities
Shinya Watanabe, Ryuhei Hayashi, Yuzuru Sasamoto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 8, 2010
Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase
Sofia Theodoropoulou, Paraskevi E Kolovou, Yuki Morizane, et al.
Cancer Research
|
May 8, 2007
MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells
Jacobus J Bosch, James A Thompson, Minu K Srivastava, et al.
Investigative Ophthalmology & Visual Science
|
May 1, 2014
Uveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase
Ahmad Al-Moujahed, Fotini Nicolaou, Katarzyna Brodowska, et al.
Page
of 7